CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 67 filers reported holding CHEMOCENTRYX INC in Q3 2015. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $10,438,000 | +36.3% | 1,410,479 | +11.3% | 0.00% | 0.0% |
Q3 2016 | $7,657,000 | +47.0% | 1,267,682 | +9.3% | 0.00% | +100.0% |
Q2 2016 | $5,209,000 | +63.5% | 1,160,147 | -9.3% | 0.00% | 0.0% |
Q1 2016 | $3,185,000 | -68.6% | 1,279,222 | +2.0% | 0.00% | -50.0% |
Q4 2015 | $10,156,000 | +23.9% | 1,253,840 | -7.5% | 0.00% | 0.0% |
Q3 2015 | $8,199,000 | -23.6% | 1,355,193 | +4.0% | 0.00% | -33.3% |
Q2 2015 | $10,725,000 | +10.4% | 1,303,124 | +1.3% | 0.00% | +50.0% |
Q1 2015 | $9,713,000 | +12.2% | 1,286,518 | +1.5% | 0.00% | 0.0% |
Q4 2014 | $8,658,000 | +61.9% | 1,267,706 | +6.7% | 0.00% | 0.0% |
Q3 2014 | $5,349,000 | -21.3% | 1,188,581 | +2.3% | 0.00% | 0.0% |
Q2 2014 | $6,800,000 | -15.5% | 1,162,397 | -4.3% | 0.00% | 0.0% |
Q1 2014 | $8,049,000 | +19.7% | 1,214,011 | +4.6% | 0.00% | 0.0% |
Q4 2013 | $6,723,000 | +73.2% | 1,161,101 | +66.3% | 0.00% | +100.0% |
Q3 2013 | $3,881,000 | -55.2% | 698,026 | +13.9% | 0.00% | -66.7% |
Q2 2013 | $8,667,000 | – | 612,973 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |